跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 143 条关于
“BDH1”
全部
143
临床试验
124
药物
7
机构
0
资讯
12
6个月前
Ketone Body β-Hydroxybutyrate Enhances CAR T Cell Therapy Efficacy in Preclinical Studies, Human Trials Underway
去年
Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma
去年
Olutasidenib Plus Azacitidine Shows Promise in IDH1-Mutated Relapsed/Refractory AML
去年
Olutasidenib Maintenance Therapy Demonstrates Sustained Remission in IDH1-Mutated AML Patients
去年
Vorasidenib Confirms Efficacy and Safety in IDH1/2-Mutant Diffuse Glioma
4年前
FDA Approves Ivosidenib Plus Azacitidine for IDH1-Mutated Acute Myeloid Leukemia
3年前
FDA Approves Olutasidenib for Relapsed or Refractory AML with IDH1 Mutation
去年
IDH1-Targeted Therapy Shows Promise in Improving MDS Patient Outcomes, ASH 2024 Data Reveals
9个月前
Ivosidenib Combination Demonstrates Real-World Efficacy in IDH1-Mutated AML, Matching Clinical Trial Results
去年
Ivosidenib Plus CPX-351 Shows Promise in IDH1-Mutated AML and High-Risk MDS Trial
第 1 页,共 2 页
上一页
下一页